Brockstedt Dirk G.
Officer at RAPT Therapeutics, Inc.; EVP of Research and Dev. at CHINOOK THERAPEUTICS, INC.
- Sold, on record
- $5.5M
- Dollars the filings state
- Form 4 sales
- 41
- Latest Jan 5, 2024
- Form 144 notices
- 1
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- RAPT Therapeutics, Inc.Officer
- CHINOOK THERAPEUTICS, INC.EVP of Research and Dev.
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- CHINOOK THERAPEUTICS, INC.244,166 shares
- RAPT Therapeutics, Inc.79,632 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale RAPT Therapeutics, Inc.Plan not statedJan 11, 2022 2022
Sold 2,648 shares at $32.16 ($85k)
Brockstedt Dirk G., Chief Scientific Officer
Sold 11.8% of holdings ($722k position)19,812 shares left1x usual sizeFiling
- 2 Form 4 sale RAPT Therapeutics, Inc.Plan not statedFeb 11, 2022 +31 days
Sold 2,647 shares at $22.47 ($59k)
Brockstedt Dirk G., Chief Scientific Officer
Sold 11.8% of holdings ($505k position)19,812 shares left1x usual sizeFiling
- 3 Form 4 sale RAPT Therapeutics, Inc.Plan not statedMar 11, 2022 +28 days
Sold 2,648 shares at $23.91 ($63k)
Brockstedt Dirk G., Chief Scientific Officer
Sold 11.8% of holdings ($537k position)19,812 shares left1x usual sizeFiling
- 4 Form 4 sale RAPT Therapeutics, Inc.Plan not statedApr 11, 2022 +31 days
Sold 2,647 shares at $23.05 ($61k)
Brockstedt Dirk G., Chief Scientific Officer
Sold 11.8% of holdings ($518k position)19,812 shares left1x usual sizeFiling
- 5 Form 4 sale RAPT Therapeutics, Inc.Plan not statedMay 4, 2022 +23 days
Sold 720 shares at $15.05 ($11k)
Brockstedt Dirk G., Chief Scientific Officer
Sold 3.5% of holdings ($309k position)19,812 shares left0.3x usual sizeFiling
- 6 Form 4 sale RAPT Therapeutics, Inc.Plan not statedJan 5, 2023 +246 days
Sold 742 shares at $21.97 ($16k)
Brockstedt Dirk G., Chief Scientific Officer
Sold 3.7% of holdings ($435k position)19,070 shares left0.3x usual sizeFiling
- 7 Form 144 notice RAPT Therapeutics, Inc.NoticeJan 5, 2024 +365 days
Filed to sell 898 shares ($20k)
Brockstedt Dirk G., Officer
No 10b5-1 plan0.3x usual sizeFiling
- 8 Form 4 sale RAPT Therapeutics, Inc.No planJan 5, 2024 same day
Sold 898 shares at $22.78 ($20k)
Brockstedt Dirk G., CHIEF SCIENTIFIC OFFICER
No 10b5-1 planSold 3.1% of holdings ($654k position)27,820 shares left0.3x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (42)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2024 | Jan 8, 2024 | RAPT Therapeutics, Inc. | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 898 | $20k | 3.1% | No plan | SEC |
| Jan 5, 2024 | Jan 5, 2024 | RAPT Therapeutics, Inc. | Officer | Form 144 notice | 898 | $20k | Notice | SEC | |
| Jan 5, 2023 | Jan 9, 2023 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 742 | $16k | 3.7% | Plan not stated | SEC |
| May 4, 2022 | May 5, 2022 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 720 | $11k | 3.5% | Plan not stated | SEC |
| Apr 11, 2022 | Apr 12, 2022 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 2,647 | $61k | 11.8% | Plan not stated | SEC |
| Mar 11, 2022 | Mar 14, 2022 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 2,648 | $63k | 11.8% | Plan not stated | SEC |
| Feb 11, 2022 | Feb 14, 2022 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 2,647 | $59k | 11.8% | Plan not stated | SEC |
| Jan 11, 2022 | Jan 13, 2022 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 2,648 | $85k | 11.8% | Plan not stated | SEC |
| Dec 10, 2021 | Dec 13, 2021 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 2,647 | $82k | 11.8% | Plan not stated | SEC |
| Nov 11, 2021 | Dec 10, 2021 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 2,648 | $95k | 11.8% | Plan not stated | SEC |
| Oct 11, 2021 | Oct 12, 2021 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 2,647 | $81k | 11.8% | Plan not stated | SEC |
| Sep 10, 2021 | Sep 13, 2021 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 2,648 | $95k | 11.8% | Plan not stated | SEC |
| Aug 11, 2021 | Aug 12, 2021 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 2,647 | $83k | 11.8% | Plan not stated | SEC |
| Jul 12, 2021 | Jul 13, 2021 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 2,648 | $89k | 11.8% | Plan not stated | SEC |
| Jun 11, 2021 | Jun 15, 2021 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 2,647 | $49k | 11.8% | Plan not stated | SEC |
| May 11, 2021 | May 13, 2021 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 2,648 | $48k | 11.8% | Plan not stated | SEC |
| May 5, 2021 | May 6, 2021 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 2,084 | $45k | 9.5% | Plan not stated | SEC |
| Feb 16, 2021 | Feb 17, 2021 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 9,877 | $210k | 33.3% | Unusual | SEC |
| Jan 6, 2021 | Jan 6, 2021 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 2,000 | $39k | 10.2% | Plan not stated | SEC |
| Nov 16, 2020 | Nov 18, 2020 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 9,877 | $168k | 49.1% | Unusual | SEC |
| Nov 2, 2020 | Nov 3, 2020 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 1,910 | $54k | 15.7% | Plan not stated | SEC |
| Aug 17, 2020 | Aug 18, 2020 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 9,877 | $236k | 49.1% | Unusual | SEC |
| May 15, 2020 | May 18, 2020 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 9,877 | $148k | 49.1% | Unusual | SEC |
| Dec 15, 2017 | Dec 15, 2017 | CHINOOK THERAPEUTICS, INC. | EVP of Research and Dev. | Form 4 sale | 65,223 | $529k | 47.3% | Unusual | SEC |
| Dec 1, 2017 | Dec 4, 2017 | CHINOOK THERAPEUTICS, INC. | EVP of Research and Dev. | Form 4 sale | 10,000 | $94k | 11.9% | Plan not stated | SEC |
| Nov 13, 2017 | Nov 14, 2017 | CHINOOK THERAPEUTICS, INC. | EVP of Research and Dev. | Form 4 sale | 5,877 | $47k | 7.4% | Plan not stated | SEC |
| Nov 6, 2017 | Nov 8, 2017 | CHINOOK THERAPEUTICS, INC. | EVP of Research and Dev. | Form 4 sale | 4,123 | $33k | 5.3% | Plan not stated | SEC |
| Oct 2, 2017 | Oct 4, 2017 | CHINOOK THERAPEUTICS, INC. | EVP of Research and Dev. | Form 4 sale | 10,000 | $106k | 11.9% | Plan not stated | SEC |
| Sep 13, 2017 | Sep 14, 2017 | CHINOOK THERAPEUTICS, INC. | EVP of Research and Dev. | Form 4 sale | 3,557 | $39k | 4.6% | Plan not stated | SEC |
| Sep 1, 2017 | Sep 6, 2017 | CHINOOK THERAPEUTICS, INC. | EVP of Research and Dev. | Form 4 sale | 10,000 | $117k | 16.9% | Plan not stated | SEC |
| Aug 7, 2017 | Aug 9, 2017 | CHINOOK THERAPEUTICS, INC. | EVP of Research and Dev. | Form 4 sale | 10,000 | $122k | 16.9% | Plan not stated | SEC |
| Jul 3, 2017 | Jul 6, 2017 | CHINOOK THERAPEUTICS, INC. | EVP of Research and Dev. | Form 4 sale | 10,000 | $110k | 16.9% | Plan not stated | SEC |
| Jun 1, 2017 | Jun 5, 2017 | CHINOOK THERAPEUTICS, INC. | EVP of Research and Dev. | Form 4 sale | 8,000 | $80k | 14.0% | Plan not stated | SEC |
| May 17, 2017 | May 18, 2017 | CHINOOK THERAPEUTICS, INC. | EVP of Research and Dev. | Form 4 sale | 1,011 | $10k | 2.0% | Plan not stated | SEC |
| May 11, 2017 | May 15, 2017 | CHINOOK THERAPEUTICS, INC. | EVP of Research and Dev. | Form 4 sale | 8,000 | $78k | 14.0% | Plan not stated | SEC |
| Apr 3, 2017 | Apr 4, 2017 | CHINOOK THERAPEUTICS, INC. | EVP of Research and Dev. | Form 4 sale | 8,000 | $86k | 14.0% | Plan not stated | SEC |
| Mar 9, 2017 | Mar 10, 2017 | CHINOOK THERAPEUTICS, INC. | EVP of Research and Dev. | Form 4 sale | 8,000 | $88k | 14.0% | Plan not stated | SEC |
| Jan 17, 2017 | Jan 19, 2017 | CHINOOK THERAPEUTICS, INC. | EVP of Research and Dev. | Form 4 sale | 8,000 | $95k | 14.0% | Plan not stated | SEC |
| May 16, 2016 | May 18, 2016 | CHINOOK THERAPEUTICS, INC. | Sr. VP of Research and Dev. | Form 4 sale | 905 | $7k | 7.0% | Plan not stated | SEC |
| Jan 11, 2016 | Jan 11, 2016 | CHINOOK THERAPEUTICS, INC. | Sr. VP of Research and Dev. | Form 4 sale | 22,000 | $479k | 64.7% | Unusual | SEC |
| Dec 10, 2015 | Dec 14, 2015 | CHINOOK THERAPEUTICS, INC. | Sr. VP of Research and Dev. | Form 4 sale | 25,000 | $745k | 100.0% | Unusual | SEC |
| Nov 17, 2015 | Nov 18, 2015 | CHINOOK THERAPEUTICS, INC. | Sr. VP of Research and Dev. | Form 4 sale | 26,470 | $750k | 100.0% | Unusual | SEC |